CymaBay Therapeutics, Inc.
Pharmaceutical company · Newark, California, United States
CymaBay Therapeutics, Inc. is a pharmaceutical company headquartered in Newark, California, United States. It has reported private securities offerings to the US SEC, most recently $324,999 sold in a notice filed in 2015.
Profile compiled from public records. Is this your company? Request a correction or update
CymaBay Therapeutics at a glance
Typepharmaceutical company
HeadquartersNewark, California, United States
SEC industryPharmaceutical Preparations
SEC CIK1042074
What does CymaBay Therapeutics do?
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $324,999 sold (2015).
Frequently asked questions about CymaBay Therapeutics
Where is CymaBay Therapeutics headquartered?
CymaBay Therapeutics, Inc. is headquartered in Newark, California, United States.
What does CymaBay Therapeutics do?
CymaBay Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Similar companies
- Protagonist Therapeutics, IncNewark, California, United States
- Rain Oncology Inc.Newark, California, United States
- Rafael Holdings, Inc.Newark, New Jersey, United States
- InCarda Therapeutics, Inc.Newark, California, United States
- Symbiomix Therapeutics, LLCNewark, New Jersey, United States
- Inergetics IncNewark, New Jersey, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences